Quick Answer
Spero Therapeutics, Inc. reported Total Assets of $68.92 million for fiscal year 2025.
Spero Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $68.92M | -37.7% |
| 2024 | $110.54M | -39.4% |
| 2023 | $182.39M | +46.1% |
| 2022 | $124.80M | -27.0% |
| 2021 | $171.07M | +11.5% |
| 2020 | $153.45M | +44.6% |
| 2019 | $106.10M | -17.8% |
| 2018 | $129.01M | +38.0% |
| 2017 | $93.48M | +578.8% |
| 2016 | $13.77M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $54.17M | -59.9% | -12.8% |
| June 30, 2025 | $62.12M | -58.6% | -20.1% |
| March 31, 2025 | $77.71M | -53.7% | -29.7% |
| December 31, 2024 | $110.54M | -39.4% | -18.2% |
| September 30, 2024 | $135.16M | +26.2% | -9.8% |
| June 30, 2024 | $149.88M | +51.6% | -10.6% |
| March 31, 2024 | $167.70M | +49.0% | -8.1% |
| December 31, 2023 | $182.39M | +46.1% | +70.3% |
- Spero Therapeutics, Inc. showed a decrease of -37.7% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Spero Therapeutics, Inc.’s total assets has grown by 400.4% (from $13.77 million to $68.92 million).
- The most recent figure is from Spero Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: